Michelle Mattingly, Ph.D., ABPP
Dr. Michelle Mattingly is an Assistant Professor in the Department of Psychiatry and Neurosciences. She is a Board Certified Clinical Neuropsychologist with experience assessing individuals with a wide variety of neurological disorders within forensic, medical and psychiatric contexts. Dr. Mattingly has specific interests in evaluating and treating those with carbon monoxide poisoning, dementia, Mild Cognitive Impairment (MCI), sports-related concussions, Parkinson’s disease, Multiple Sclerosis, brain tumors, Traumatic Brain Injury (TBI), and epilepsy. In particular, she has considerable expertise in the medical-legal evaluation of neurocognitive dysfunction of children and adults following carbon monoxide exposure and TBI. Her research interests include evaluating the cognitive sequelae of carbon monoxide and sports-related concussions.
Eric Rinehardt, Ph.D., ABPP
Dr. Rinehardt is an Assistant Professor in the Department of Psychiatry and Neurosciences and the Clinical Coordinator of the Memory Disorders Clinic. He is a Board Certified Clinical Neuropsychologist with experience assessing individuals with a wide variety of neurological disorders. Dr. Rinehardt has specific interests in evaluating and treating those with Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI), Parkinson’s disease (PD), Multiple sclerosis (MS), brain tumors, Traumatic Brain Injury (TBI), and sports-related concussions. His research interests include identifying cognitive and biological markers which predict progression from MCI to AD, reliably assessing cognitive changes over time, and evaluating the cognitive sequelae of sports-related concussions.
Mike Schoenberg, Ph.D., ABPP (Chief of Neuropsychology Division)
Dr. Schoenberg has broad research interests in the neuropsychological correlates of epilepsy, predicting outcome of neurosurgical procedures, and the diagnostic and ecological validity of neuropsychological tests. He is currently involved in research projects to better predict outcome from temporal lobectomy for treatment of medication refractory epilepsy as well as DBS for treatment of movement disorders (Parkinson's disease and Tourette's syndrome). Related to interests in epilepsy and head injury, Dr. Schoenberg has interests in post-traumatic epilepsy, traumatic brain injury (concussion), rehabilitation following stroke/TBI, and anatomical correlates of learning and memory. He has a long standing interest in neurodegenerative disorders and mild cognitive impairment (MCI). Finally, Dr. Schoenberg remains interested in evaluating the cognitive and behavioral effects of medications as it relates to better characterizing outcome from treatment for epilepsy, movement disorders, and traumatic brain injury/concussions.